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Pediatric brain tumors are a type of tumors that are commonly
present in children and young adults. With the improvement of
treatment, the quality of life, especially the cognitive functioning,
is gaining increasingly more attention. Apart from cognitive
evaluations, neuroimaging studies begin to play an important part
in neurocognitive functioning investigation. In this way, the brain
tissue changes caused by tumor variables (including tumor location
and tumor size) and treatment variables (including surgery,
chemotherapy and radiotherapy) can be detected by neuroimaging.
Recent advancement of neuroimaging techniques, such as functionalMRI (fMRI) and diffusion tensor imaging (DTI), made great contributions to understanding cognitive dysfunction and quantifying
the effects of tumor variables and treatment variables. In recent
years, laminar-fMRI provided a potentially valuable tool for examining
the exact origins of neural activity and cognitive function. On the
other hand, molecular fMRI might guide diagnosis and treatment
of brain disease in the future by using new biomarkers, and DTI
can detect white matter changes and obtain some anatomically
specific information.
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function,

Introduction

Childhood cancers can be classified into tumors
in brain, cardiac, respiratory, digestive tract, and
other organs. Brain tumors, accounting for about
30% of all childhood cancers [1], are difficult to
treat. Although the survival rate has reached
above 60%, the decline in quality of life, especially
the cognitive deficits, still presents an important
issue which receives increasing attention from

pediatric neurosurgeons and psychologists.
There are many related factors that contribute
to cognitive function, such as the tumor itself,
the treatment, the patient, and environmental
characteristics. In regard to psychosocial care, the
Children’s Oncology Group and the Psychosocial
Standards of Care Project for Childhood Cancer
have made great contributions [2, 3]. The National
Cancer Institute Brain Tumor Progress Review
Group Report suggests that routine cognitive and
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quality-of-life assessment should become the
standard of care for patients with brain tumor.
Many investigators began to emphasize the
importance of baseline assessment for cognitive
evaluation, because without it we cannot
differentiate the most related factors or identify
the true risks in the treatment variables [4, 5].
Although there is a number of neurocognitive
examinations, neurocognitive studies have reached
a state of so-called “stagnation”. However, the
emergence of neuroimaging studies in recent
decades, which provides us with more visual and
convincing demonstration, has led to increased
interest in neurocognitive studies among multiple
researchers.

2

Tumor variables

2.1 Tumor location
Most of pediatric brain tumors are located in
deep brain areas, around the midline, such as
suprasellar area, pineal gland, the 3rd ventricle,
the 4th ventricle, and even the basal ganglia.
Investigations imply that memory impairment is
always related to these locations [5]. It has been
suggested that these deficits occur due to existence
of extensive connections among basal ganglia,
the cerebral cortex, and the limbic cortex [5, 7].
Brain tumors can infiltrate and/or displace brain
tissue, increase intracranial pressure, cause
seizures, and disrupt structural and functional
brain connectivity—all of these factors can contribute to cognitive deficits. Liang et al. [6] found
that tumors in basal ganglia are associated with
worse neuropsychological outcomes, including
motor dysfunction, memory loss and emotional
impairment. Tumors in suprasellar area and pineal
gland may also have effect on neurocognitive
function due to hormone deficiencies [8, 9],
although this requires more evidence. We all know
that cortical areas (such as primary motor area,

somatosensory area, Wernicke’s area, and Broca’s
area) are associated with cognition. In a diseased
brain, the location of these regions needs to be
discovered in order to precisely determine the
resection areas [10, 11]. It has been considered
that the cerebellum’s function was limited to
motor control and coordination. However, it has
been demonstrated via diffusion tensor imaging
(DTI) that the cerebellum is involved in cognitive
functioning through cerebello-cerebral network
[12]. It has been suggested that deep and periventricular tumors may cause memory impairment
more than the superficial and frontally positioned
brain tumors [5]. Sometimes, the effect of tumors’
location on cognition depends on the associated
complications rather than the location itself. For
example, hydrocephalus secondary to posterior
fossa tumor has been shown to correlate with
neurocognitive deficits [13].
2.2 Tumor size
It was thought that tumor size had no correlation
with cognitive function, but now studies have
shown that it indeed affects the radiation field
and may cause hydrocephalus, thus results
in cognitive deficits [14]. A large-scale study
examined the relationship between tumor size
and sex, and found that boys had larger brain
tumors than girls: boys have larger cranial volumes,
which was assumed to be the reason for larger
brain tumors in boys [15]. This finding suggests
that gender should be considered as a potential
risk factor on cognition assessment in pediatric
brain tumor patients.

3

Treatment

3.1 Surgery
The effect of surgery on cognitive function depends
on the neurosurgeon’s experience, surgical intervention itself (type of surgical intervention),

https://mc03.manuscriptcentral.com/brainsa

| Brain Science Advances

119

Brain Sci. Adv.

surgical approach, and eventual complications.
The advances in neurosurgical techniques in the
past few decades have decreased the morbidity
and mortality. Few studies have explored the
isolated effect of surgery on neurocognition, due
to the fact that most pediatric brain tumors are
treated by surgery in combination with chemotherapy and radiotherapy, but rarely alone.
According to some researchers, transient deficits
always occur after surgery (e.g. memory declining
and posterior fossa syndrome) [16–18]. Memory
and attention, which are crucial in new knowledge
attaining, are likely to be affected the most after
surgery [19].
3.2 Chemotherapy
There is also little understanding on the effect of
chemotherapy on neurocognition in pediatric
patients with brain tumor. However, knowledge
about chemotherapy for other cancers can serve
as reference for its treatment. Some researchers
suggest that chemotherapy has no significant
medical impact, while others insist that there
is a decrease in neurocognition in survivors.
Chemotherapy may lead to cognitive deficits in
acute phase, without as many long-term negative
effects as seen in radiotherapy [20]. And it was
reported that high-dose chemotherapy regimens
were associated with transient, treatment-related
white matter changes, lasting for about 6 months
at most [21]. However, investigation on the effects
of standard-dose chemotherapy on cognitive
function is still lacking, and more research is
needed to clarify if the effect of chemotherapy is
reversible or causes long-term delayed damage.
Investigations show that some chemotherapy
agents can carry direct and indirect risks for
cognitive impairment [22–26]. Particular agents
can damage not only the brain parenchyma but
also the white matter by crossing the blood–brain
barrier (BBB) [27]. For example, the frequently

http://bsa.tsinghuajournals.com

used chemotherapeutic agent, 5-fluorouracil,
can cross BBB simply by diffusion [27]. The
neurocognitive declines often depend on the
components of those agents. In other words, it
has been suggested that the chemotherapy agents,
which is applied to the pediatric brain tumor
patients, may have little effect on restoring
cognitive functioning, although we still need
more evidence. Additionally, the changes in grey
and white matter are usually reversible after
chemotherapy treatment [17].
3.3 Radiotherapy
Radiotherapy is accepted as the most deleterious
treatment that has the highest risk for cognitive
deficit in pediatric patients [28, 29]. White matter
and the hippocampus are especially sensitive
to damage caused by radiotherapy [30–35], and
some studies also indicate that memory loss is
caused by global brain dysfunction after cranial
irradiation [2, 31].
Injuries resulting from radiation can be seen
in three phases. In the acute phase, disruption of
BBB can induce some common symptoms, such
as nausea, headache, and worsening of neurologic
deficits. Cognitive problems existing in earlydelayed phase are reversible in most cases,
however, some may indeed develop into radiation
somnolence syndrome or focal encephalopathy.
This might be caused by BBB disruption or
oligodendrocyte injuries. Effects in late-delayed
phase are always irreversible and progressive, and
appear as a result of ischemia, demyelination of
white matter, and necrosis. Related risk factors
include the radiated tissue volume, the total dose
of radiation, and concomitant chemotherapy [36].
Cranial radiation therapy and chemotherapy
have synergistic action via vascular changes,
cerebral calcifications, demyelination, and BBB
permeability. Radiotherapy and chemotherapy
can affect attention due to white matter loss [20].
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4.1

Neuroimaging advancement

In contrast to the relatively large amount of
researches that used cognitive assessments, such
as the Wechsler Intelligence Scale, the neuroimag-

Electroencephalogram (EEG) and electrocorticography (ECoG)

EEG records bioelectrical activity of the brain
through electrodes placed on the scalp. It was first
applied by a British physician, Richard Caton,

ing studies are much less prevalent. However,

who tried to observe electrical impulses from the

neuroimages have great value in identifying

living brains of rabbits and monkeys in 1875.

subtle neural structural changes and/or circuits

EEG is known for its portability, affordability

[20]. This may help uncover the neural basis

and high temporal resolution, but has problems

for cognitive deficits. In the late 20th century, the

of attenuation and distortion of signals. On the

development of neuroimaging methodologies

contrary, ECoG can also detect the electrical

was crucial for cognitive function assessment

discharges of the cortex with better signal

in cortical motor regions [37]. Functional brain

accuracy. Both of these techniques can be used

mapping was used as a tool to determine the

for epileptogenic mapping and speech and motor

boundaries between brain tumors with variable

mapping, but ECoG is an invasive technique [10].

tumor site and healthy brain tissue [10]. Direct
electrical stimulation (DES) may be the oldest

4.2 fMRI

mapping technique. It is the “golden standard”

fMRI is used for language lateralization and

at present, however, it’s still being criticized for

preoperative mapping of higher cortical regions,

its invasiveness [38] and its possibility to induce

and has a high validity against DES, which is the

seizures [10]. Older studies have demonstrated that

“golden standard” for brain function mapping.

structural brain changes affect its function. New
imaging techniques, such as positron emission
computed tomography (PET) and functional-MRI
(fMRI), greatly promote our understanding about
the relationship between anatomy and cognitive
function. PET uses radioactive agents as tracer,
such as 15O. Deoxygenated hemoglobin is more
sensitive to the magnetic field. fMRI measures
the ratio of hemoglobin and deoxygenated
hemoglobin, which is called blood oxygenation

Neurons acquire energy from the adjacent
capillaries via oxygen and nutrient diffusion from
blood, which can be visualized by fMRI images
obtained by blood oxygen level-dependent
(BOLD) technique [39]. But in order to exclude
false positive results, large numbers of image
samples are needed in cognitive studies [40]. As
a measurement of cognitive functioning, EEG has
advantage in temporal resolution, while fMRI
has superiority in spatial resolution. Efforts have
been made to combine these two, but it is too

level-dependent (BOLD) effect. Compared to

difficult to realize due to sophisticated signal

PET, fMRI has some advantages. Firstly, it can be

processing and high software requirements [41–43].

more commonly used in clinics. Secondly, without

fMRI has excellent whole brain coverage, and it

radioactive elements, fMRI can be measured

shows more visual structure than EEG, therefore,

repeatedly, in order to obtain whole data and

is more commonly used than EEG in cognitive

comprehensive understanding. Lastly, fMRI can

neuroscience research [44]. To analyze fMRI

detect about 3 cubic millimeter voxel, in this way,

images, functional segregation and functional

high spatial resolution can be obtained.

integration focus on specific brain regions and
https://mc03.manuscriptcentral.com/brainsa
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the relationship or connectivity between them,
respectively [39].
Resting-state fMRI is based on spontaneous
BOLD signal fluctuation without task requirement.
So it is often used in neurological and neurosurgical conditions, especially for pediatric patients
[45]. In task-based fMRI, the changes associated
with specific tasks can provide brain function
mapping. For example, fMRI plus the Sternberg
task can reveal the necessary functional regions
responsible for normal working memory performance, or sometimes for other working memory
paradigms [11].
Laminar fMRI is a kind of fMRI method to
record neural activity. Neural activity is highly
inter-connective in each brain area, sending
commands by top-down signals and receiving
sensory signals by bottom-up signals [46–49].
Traditional fMRI is able to detect both top-down
and bottom-up responses. To distinguish these
two kinds of signals, invasive form of EEG has
been used in animals before. But for human beings,
recent development of laminar-fMRI provides
an opportunity to acquire the same information
without the use of invasive procedures [49–51].
The feed forward, feedback and horizontal responses can be shown by means of laminar fMRI,
an in vivo measurement for neural activity [52].
However, this is not a direct tool, instead, it
identifies the BOLD response towards the cortical
surface [53]. The neocortex, a massively recurrent
network that occupies around 90% of the brain
cortex, consists of 6 layers of grey matter [54–58].
Also, the brain function depends on inter-area
and inter-laminar communication [47, 59]. By
using laminar fMRI, the origins of neural activity
can be examined, and information in all domains
of cognitive neuroscience may be acquired [52].
Molecular fMRI is another form of fMRI used
to examine the neural activity. It uses fluorescent
dyes and proteins that can reach deep brain

http://bsa.tsinghuajournals.com

regions. These specific dyes and proteins influence
magnetic signals but not the visible light, therefore
they are perfectly suited for deep brain scanning
[60, 61]. Molecular fMRI achieves great progress
in animal research, and it can be applied to
human in order to study cognitive functioning.
Moreover, molecular fMRI may guide diagnosis
and treatment of brain diseases by defining new
biomarkers or mechanically significant hallmarks
of neural processing [62]. The application of
molecular fMRI mainly lies not only in examining
neural correlations with cognitive process, but
also in guiding diagnosis and treatment of brain
diseases.
4.3 DTI
White matter plays an important role in interconnecting different brain regions and information
transfer. Therefore, the integrity of brain white
matter pathways contributes a lot to the complex
cognitive tasks [26]. MRI is a common, clinically
used neuroimaging tool, which can not only
provide images of superior quality but also avoid
damages caused by ionizing radiation (e.g. in CT
scan) or radioactive tracers (e.g. in PET). Until
now, DTI has been the only technique available
for white matter tract imaging. DTI is important
in pre-operative planning and post-operative
follow-up [10]. It provides an opportunity to detect
microstructural white matter changes, and detect
associations between functional and structural
abnormalities [63]. With sufficient sensitivity, DTI
may be good at investigating neuronal substrate
of therapy-induced cognitive deficits [27]. DTI
has also been demonstrated to be valid for
language mapping, when compared to DES [10].
DTI can provide a non-invasive assessment of
white matter construction. Sometimes, it may
be even more sensitive to subtle changes in the
microstructure of white matter fiber tracts
and shows more detailed information than the
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cognitive scales [14, 64]. In this way, DTI can be
used to analyze whether white matter damage is
involved in cognitive decline.
With the help of DTI, various measures can be
applied clinically, including mean diffusivity
(MD), fractional anisotropy (FA), radial diffusivity
(RD), and axial diffusivity (AD). MD reflects the
overall diffusion magnitude, while RD and AD
reflect the average diffusion. Reduced FA values
are found in cases of demyelination [65, 66],
edema [67, 68], gliosis [69], inflammation [70, 71],
increased axon diameter [72], lower axonal
packing density [73], tortuosity [74], and increased
membrane permeability [75].
The analysis of DTI data also consists of voxelbased analysis (VBA), region-of-interest (RIO)
analysis, histogram, and fiber tractography (FT).
VBA can be used to detect potential group
differences without prior knowledge or hypothesis
on the extent and location of the tumor. It is a
fully-automatic procedure, which requires wellaligned brain tissue. We could analyze tissue
density or volume differences through VBA
quantitation in T1 or DTI. The techniques can
divide the brain into grey matter, white matter
and cerebrospinal fluid. RIO analysis is commonly
used to acquire the underlying data value but
it takes much time to get the results, so it is not
suitable for large data. Histogram is sensitive and
automatic, while it is fit for dealing with global
diffuse effect, not indicating the lesion site. FT
provides virtual reconstruction of white matter
pathways by integrating the DTI measurements
anatomically. However, FT needs high quality
diffusion weighted imaging (DWI) data to
minimize the error accumulation [26].
DTI is a very sensitive integrity detector
of white matter. A promising approach of fiber
tractography can obtain some specific information
anatomically. Complementary data gained by
tractometry represent a proposed multi-modal

way to quantify specific microstructural properties
along white matter fibers.
However, the use of DTI is also being discussed
due to its drawbacks as it is based on the measurement of diffusion of water molecules. Brain
tumors can influence the diffusion properties,
changing the apparent anatomy of fiber tracts.
In addition, intraoperative brain shift may lower
the accuracy of DTI [10]. Although there are
numerous pitfalls for acquiring, processing,
analyzing and interpreting the data, DTI is still
valuable, especially when it is combined with
fMRI or trans-cranial magnetic stimulation, etc.
It is suggested to combine fMRI and DTI as this
combination can provide precise cortical mapping
and white matter tract mapping at the same time,
allowing for greater accuracy [10].

5

Conclusion

Pediatric brain tumors account for about 30% of
all childhood cancers. Neurocognitive function,
an important aspect of quality of life, used to
be assessed only by cognitive scale. However,
new neuroimaging techniques have been shown
as excellent tools for cognitive function analysis
because they can help us distinguish subtle
changes in brain tissue. Furthermore, laminar
fMRI can help provide information and help us
understand all domains of cognitive neuroscience,
which couldn’t be explored by traditional fMRI.
Apart from that, molecular fMRI can visualize
deep brain regions by using special fluorescent
dyes and proteins which can help us to examine
neural correlations in cognitive processes. DTI
is sensitive to fiber changes in white matter,
therefore, can help analyze cognitive decline
caused by white matter injury (induced by tumor
itself or treatment variables). All mentioned
neuroimaging techniques provide us with
qualitative and quantitative measurements and,
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if applied in neurocognitive functioning analysis,
will make a great contribution to neurocognitive
defect analysis.
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